DK0476045T3 - Bionedbrydelige polymerer til lægemiddel-afgivelse i knogler - Google Patents

Bionedbrydelige polymerer til lægemiddel-afgivelse i knogler

Info

Publication number
DK0476045T3
DK0476045T3 DK90909880.8T DK90909880T DK0476045T3 DK 0476045 T3 DK0476045 T3 DK 0476045T3 DK 90909880 T DK90909880 T DK 90909880T DK 0476045 T3 DK0476045 T3 DK 0476045T3
Authority
DK
Denmark
Prior art keywords
bones
drug delivery
biodegradable polymers
bone
delivery
Prior art date
Application number
DK90909880.8T
Other languages
Danish (da)
English (en)
Inventor
Robert S Langer
Tobin N Gerhart
Cato T Laurencin
Abraham J Domb
Wilson C Hayes
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of DK0476045T3 publication Critical patent/DK0476045T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents
    • A61L2300/414—Growth factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Polyesters Or Polycarbonates (AREA)
DK90909880.8T 1989-06-05 1990-06-01 Bionedbrydelige polymerer til lægemiddel-afgivelse i knogler DK0476045T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36122289A 1989-06-05 1989-06-05

Publications (1)

Publication Number Publication Date
DK0476045T3 true DK0476045T3 (da) 1996-09-16

Family

ID=23421153

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90909880.8T DK0476045T3 (da) 1989-06-05 1990-06-01 Bionedbrydelige polymerer til lægemiddel-afgivelse i knogler

Country Status (8)

Country Link
EP (1) EP0476045B1 (fr)
JP (1) JPH05503286A (fr)
AT (1) ATE141804T1 (fr)
CA (1) CA2056384C (fr)
DE (1) DE69028303T2 (fr)
DK (1) DK0476045T3 (fr)
ES (1) ES2093647T3 (fr)
WO (1) WO1990015586A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5328695A (en) * 1983-03-22 1994-07-12 Massachusetts Institute Of Technology Muscle morphogenic protein and use thereof
US5206023A (en) * 1991-01-31 1993-04-27 Robert F. Shaw Method and compositions for the treatment and repair of defects or lesions in cartilage
DE69232555T2 (de) * 1991-02-01 2002-10-31 Massachusetts Inst Technology Biologisch abbaubare Polymermischungen zur Arzneistoffabgabe
FR2673843B1 (fr) * 1991-03-14 1995-01-13 Centre Nat Rech Scient Composition pharmaceutique implantable, bioresorbable a base de poly(acide lactique), destinee a mettre en óoeuvre une antibiotherapie interne locale.
ATE142460T1 (de) * 1991-06-21 1996-09-15 Genetics Inst Osteogene proteine enthaltende arzneimittel
US5171579A (en) * 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
CA2119090A1 (fr) * 1993-03-26 1994-09-27 Wayne R. Gombotz Compositions pour la liberation controlee de tgf-.beta. biologiquement actif
CA2175049A1 (fr) * 1993-10-28 1995-05-04 Timothy Ringeisen Procede et dispositif ameliores permettant de traiter et guerir une cavite osseuse
US5981825A (en) 1994-05-13 1999-11-09 Thm Biomedical, Inc. Device and methods for in vivo culturing of diverse tissue cells
DE19521642C2 (de) * 1995-06-14 2000-11-09 Aesculap Ag & Co Kg Implantat, seine Verwendung in der Chirurgie und Verfahren zu seiner Herstellung
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6384105B1 (en) * 1999-04-16 2002-05-07 William Marsh Rice University Poly(Propylene Fumarate) cross linked with Poly(Ethylene Glycol)
IL140017A (en) * 2000-11-30 2009-09-22 Abraham J Domb Polyhedra
EP1228772A1 (fr) * 2001-02-01 2002-08-07 AM-Pharma B.V. Nouveau ciment osseux contenant des principes actifs
US8143368B2 (en) 2004-12-23 2012-03-27 Massachusetts Institute Of Technology Disposable medical supplies from hydrolytically biodegradable plastics
CA2970617C (fr) 2014-12-18 2021-11-23 Dexcel Pharma Technologies Ltd. Copolymeres de poly(ester-anhydride) alternes et semi-alternes
EP3237488A1 (fr) * 2014-12-18 2017-11-01 Université de Bordeaux Particules polymères et biomatériaux les comprenant
CA3057766A1 (fr) 2017-03-29 2018-10-04 Dexcel Pharma Technologies Ltd. Compositions contenant des copolymeres biodegradables

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4186448A (en) * 1976-04-16 1980-02-05 Brekke John H Device and method for treating and healing a newly created bone void
DK154260C (da) * 1981-02-20 1989-05-22 Mundipharma Gmbh Fremgangsmaade til fremstilling af et knogleimplantat af braendt tricalciumphosphat, specielt til udfyldning af hulrum eller til sammensaetning af knogledele efter fraktur.
US4761289A (en) * 1986-10-10 1988-08-02 International Minerals & Chemical Corp. Sustained release implant and method for preparing same
US4952403A (en) * 1987-06-19 1990-08-28 President And Fellows Of Harvard College Implants for the promotion of healing of meniscal tissue
DE3734223A1 (de) * 1987-10-09 1989-04-20 Boehringer Ingelheim Kg Implantierbares, biologisch abbaubares wirkstofffreigabesystem
FI83729C (fi) * 1987-11-26 1991-08-26 Biocon Oy Kirurgisk implantat.
WO1990009783A1 (fr) * 1989-02-22 1990-09-07 Massachusetts Institute Of Technology Systeme d'acheminement a liberation regulee de facteurs bioactifs

Also Published As

Publication number Publication date
EP0476045A1 (fr) 1992-03-25
ES2093647T3 (es) 1997-01-01
CA2056384A1 (fr) 1990-12-06
JPH05503286A (ja) 1993-06-03
WO1990015586A3 (fr) 1991-03-21
CA2056384C (fr) 1998-06-23
DE69028303D1 (de) 1996-10-02
DE69028303T2 (de) 1997-01-30
ATE141804T1 (de) 1996-09-15
WO1990015586A2 (fr) 1990-12-27
EP0476045B1 (fr) 1996-08-28

Similar Documents

Publication Publication Date Title
DK0476045T3 (da) Bionedbrydelige polymerer til lægemiddel-afgivelse i knogler
BR9402861A (pt) Composição adesiva, biocompatível, biodegradável e não tóxica, biomaterial e material adesivo
FI883594A0 (fi) Hedelmöitystä ehkäisevä implantti
SE8902288L (sv) Farmaceutisk komposition
WO2004071356A3 (fr) Dispositifs resorbables
DE69010764D1 (de) Verfahren für chirurgische Implantate.
SE8803321D0 (sv) Fordrojd och styrd frigoring av vattenolosliga polypeptider
NO995301D0 (no) Bionedbrytbare sammensetninger omfattende poly(cykloalifatisk fosfoester) forbindelser, artikler og fremgangsmÕte for anvendelse derav
FR2663836B1 (fr) Implant orthopedique ou dentaire multibloc.
CA2111193A1 (fr) Composition comprenant de la fibrine ou du fibrinogene et un polymere biodegradable et biocompatible utilise pour traiter les tissus
ATE40519T1 (de) Implantat mit resorbierbarem schaft.
DE69426740D1 (de) Antibakterielle Gefässprothese und chirurgisches Nahtmaterial
NO970589L (no) Formuleringer og metoder for å tilveiebringe forlenget lokal bedövelse
DE69026100T2 (de) Biologisch abbaubarer und resorbierbarer Formkörper für chirurgischen Gebrauch
FR2693108B3 (fr) Matériau chirurgical résorbable en particulier fil de suture résorbable.
ATE353197T1 (de) Biodegradierbare chirurgische implantate
BR9106030A (pt) Composicao vitrea bioativa para implantes osseos
ES2063333T3 (es) Implante para uso en cirugia de huesos.
DK1071483T3 (da) Knogleimplantat
GB2366738A (en) Including a body of non-resorbable bioactive material implant
FR2659224B1 (fr) Repere chirurgical, et mesureur, notamment pour prothese de hanche, mettant en óoeuvre un tel repere.
DK0782865T3 (da) Resorberbare, fysiologisk acceptable copolymerer og anvendelse deraf
DE60022776D1 (de) Verfahren und material zur hämostase bei knochen
IT1241478B (it) Composizioni farmaceutiche a base di calcitonina, somministrabili per via endonasale, per il controllo del calcio sierico e del dismetabolismo osseo.
FR2794982B1 (fr) Materiau de greffe osseuse forme d'une ceramique phosphocalcique et de tissu osseux